Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5424-02-2

Post Buying Request

5424-02-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5424-02-2 Usage

Description

2-CHLORO-4'-HYDROXYCHALCONE is a chalcone derivative with the molecular formula C15H9ClO2, featuring both chloro and hydroxy functional groups. It has been studied for its potential biological properties, such as antioxidant and anti-inflammatory activities, and is considered a promising compound for various therapeutic applications.

Uses

Used in Pharmaceutical Industry:
2-CHLORO-4'-HYDROXYCHALCONE is used as a pharmaceutical intermediate for the synthesis of various drugs, leveraging its unique chemical structure and functional groups.
Used in Antioxidant Applications:
2-CHLORO-4'-HYDROXYCHALCONE is used as an antioxidant agent, providing protection against oxidative stress and potentially contributing to the prevention of various diseases associated with oxidative damage.
Used in Anti-inflammatory Applications:
2-CHLORO-4'-HYDROXYCHALCONE is used as an anti-inflammatory agent, helping to reduce inflammation and alleviate symptoms in various inflammatory conditions.
Used in Research and Development:
2-CHLORO-4'-HYDROXYCHALCONE is used in research and development for exploring its potential therapeutic applications and understanding its biological properties, including its antioxidant and anti-inflammatory activities.

Check Digit Verification of cas no

The CAS Registry Mumber 5424-02-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5424-02:
(6*5)+(5*4)+(4*2)+(3*4)+(2*0)+(1*2)=72
72 % 10 = 2
So 5424-02-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H11ClO2/c16-14-4-2-1-3-11(14)7-10-15(18)12-5-8-13(17)9-6-12/h1-10,17H/b10-7+

5424-02-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2-Chlorophenyl)-1-(4-hydroxyphenyl)-2-propen-1-one

1.2 Other means of identification

Product number -
Other names 2-Chlor-4'-hydroxy-chalkon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5424-02-2 SDS

5424-02-2Relevant articles and documents

Synthesis and anticancer activity of chalcone–quinoxalin conjugates

Ma, Xiaoyun,Wang, Daoping,Wei, Gang,Zhou, Qingdi,Gan, Xiuhai

, p. 1363 - 1372 (2021/02/21)

Two series of quinoxaline–chalcone conjugates have been prepared by aldolic condensation and aromatic nucleophilic substitution reaction, and their anticancer activity against three cancer cell lines including benign prostatic hyperplasia epithelial cell (BPH-1), neuron-like rat pheochromocytoma cell line (PC12) and human breast cancer cell line (MCF-7) were evaluated in?vitro. All of the synthesized compounds exhibited moderate to good activity against the cancer cell lines selected. Particularly, Compound A5 showed the excellent potent activity against BPH-1 and MCF-7 with IC50 values of 10.4 and 9.1 μM, respectively, which is similar to doxorubicin (14.1 and 9.2 μM, respectively). As well as compound B6 exhibited most excellent activity toward PC12 with IC50 values of 16.4 μM. Compound A10 exhibited 55.4, 36.8 and 54.5 folds higher selectivity for BPH-1, PC12 and MCF-7 cells than for HEK-293 cell, respectively. In addition, theoretical biological activities of compounds A5 and A10 were evaluated by SwissADME.

Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, in silico docking and in vitro cytotoxicity analysis

Chaudhary, Monika,Kumar, Neeraj,Baldi, Ashish,Chandra, Ramesh,Arockia Babu,Madan, Jitender

, p. 200 - 218 (2019/03/08)

With an endeavor to develop novel curcumin analogs as potential anti-cancer agents, we designed and synthesized a series of Knoevenagel condensates by clubbing pyrazole carbaldehydes at the active methylene carbon atom of the curcumin backbone. Molecular docking studies were carried out to target the proposed derivatives on human kinase β (IKKβ), a potential anti-cancer target. The chloro derivative displayed five hydrogen bond interactions with a docking score of ?11.874 kcal/mol higher than curcumin (docking score = ?7.434 kcal/mol). This was supported by the fact that the propellant shaped derivatives fitted aptly into the binding pocket. Molecular simulations studies were also conducted on the lead molecule and the results figured out that the stable complexes were developed as the minimal deviations per residue of protein within the range of 0.11–0.92 ?. The screened compounds were synthesized, characterized and evaluated in vitro for cytotoxicity against cervical cancer cell line, HeLa using standard cell proliferation assay. Chloro derivative and bromo analog demonstrated IC50 (half maximal inhibitory concentration) value of 14.2 and 18.6 μg/ml, respectively, significantly lower than 42.4 μg/ml of curcumin and higher than 0.008 μg/ml of paclitaxel. Induction of apoptosis was evaluated in the terms of cleavage of caspase-3 enzyme and they also exhibited 69.6 and 65.4% of apoptosis significantly higher than 19.9% induced by curcumin. In conclusion, chloro and bromo derivatives must be evaluated under a set of stringent in vitro and in vivo parameters for translating in to a clinically viable product. Communicated by Ramaswamy H. Sarma.

Biological activity evaluation and action mechanism of chalcone derivatives containing thiophene sulfonate

Guo, Tao,Xia, Rongjiao,Chen, Mei,He, Jun,Su, Shijun,Liu, Liwei,Li, Xiangyang,Xue, Wei

, p. 24942 - 24950 (2019/08/21)

A series of novel chalcone derivatives containing a thiophene sulfonate group were designed and synthesized. The structures of all title compounds were determined by 1H-NMR, 13C-NMR and HRMS. Antibacterial bioassays indicated that, compound 2l demonstrated excellent antibacterial activities against Xanthomonas axonopodis pv. citri (Xac), with an EC50 value of 11.4 μg mL-1, which is significantly superior to those of bismerthiazol (BT) (51.6 μg mL-1) and thiodiazole-copper (TC) (94.7 μg mL-1). Meanwhile, the mechanism of action of compound 2l was confirmed by using scanning electron microscopy (SEM). In addition, compound 2e showed remarkable inactivation activity against Tobacco mosaic virus (TMV), with an EC50 value of 44.3 μg mL-1, which was superior to that of ningnanmycin (120.6 μg mL-1). Microscale thermophoresis (MST) also showed that the binding of compounds 2e and 2h to Tobacco mosaic virus coat protein (TMV-CP) yielded Kd values of 0.270 and 0.301 μmol L-1, which are better than that of ningnanmycin (0.596 μmol L-1). At the same time, molecular docking studies for 2e and 2h with TMV-CP (PDB code: 1EI7) showed that the compound was embedded well in the pocket between the two subunits of TMV-CP in each case. These results suggested that chalcone derivatives containing a thiophene sulfonate group may be considered as activators in the design of antibacterial and antiviral agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5424-02-2